Table 1.
Associations between AGTRAP mRNA expression and clinicopathological characteristics in HCC.
| Characteristics | cases | Low expression of AGTRAP (%) | High expression of AGTRAP (%) | P value |
|---|---|---|---|---|
| 134 (50.2) | 133 (49.8) | |||
| Age | 0.762 | |||
| <=60 | 126 | 64 (24.0) | 62 (23.2) | |
| >60 | 141 | 69 (25.8) | 72 (27.0) | |
| Gender | 0.965 | |||
| Female | 92 | 46 (17.2) | 46 (17.2) | |
| Male | 175 | 87 (32.6) | 88 (33.0) | |
| Weight | 0.126 | |||
| <=70 | 141 | 64 (24.0) | 77 (28.8) | |
| >70 | 126 | 69 (25.8) | 57 (21.3) | |
| Race | 0.942 | |||
| Asian | 120 | 61 (22.8) | 59 (22.1) | |
| Black or African American | 11 | 5 (1.9) | 6 (2.2) | |
| White | 128 | 64 (24.0) | 64 (24.0) | |
| Pathologic stage | 0.145 | |||
| Stage I | 250 | 181 (67.8) | 69 (25.8) | |
| Stage II | 60 | 22 (8.2) | 38 (14.2) | |
| Stage III | 53 | 28 (10.5) | 25 (9.4) | |
| Stage IV | 4 | 2 (0.7) | 2 (0.7) | |
| T stage | 0.146 | |||
| T1 | 152 | 82 (30.7) | 70 (26.2) | |
| T2 | 60 | 22 (8.2) | 38 (14.2) | |
| T3 | 51 | 27 (10.1) | 24 (9.0) | |
| T4 | 4 | 2 (0.7) | 2 (0.7) | |
| N stage | 0.996 | |||
| N0 | 265 | 132 (49.4) | 133 (49.8) | |
| N1 | 2 | 1 (0.4) | 1 (0.4) | |
| M stage | 0.994 | |||
| M0 | 264 | 131 (49.1) | 133 (49.8) | |
| M1 | 4 | 2 (0.7) | 2 (0.7) | |
| Histologic grade | 0.032* | |||
| G1 | 22 | 13 (24.0) | 9 (3.4) | |
| G2 | 133 | 76 (25.8) | 57 (21.3) | |
| G3 | 100 | 40 (13.6) | 60 (22.5) | |
| G4 | 12 | 4 (1.1) | 8 (3.0) | |
| AFP (ng/ml) | 0.335 | |||
| <=400 | 202 | 104 (41.1) | 98 (36.7) | |
| >400 | 125 | 29 (10.7) | 96 (36.0) | |
| Albumin (g/dl) | 0.084 | |||
| <3.5 | 60 | 24 (13) | 36 (13.5) | |
| >=3.5 | 207 | 109 (39.3) | 98 (36.7) |
* means p<0.05.